| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/28/2004 | CN1515192A Health-care beverage for relieving acute alcoholism |
| 07/28/2004 | CN1515170A Pueraria flower tea capable of dispelling effects of liquor |
| 07/28/2004 | CN1159439C Pantropic neurotrophic factors |
| 07/28/2004 | CN1159316C Iso-Indolo-indolone compound, their preparation methods and drug compositions comprising the same |
| 07/28/2004 | CN1159307C Method for preparing xitaipulan |
| 07/28/2004 | CN1159300C Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159287C Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 07/28/2004 | CN1159059C Medicine for abstinence of drugs and its prepn. |
| 07/28/2004 | CN1159025C Chinese medicine for optimally taking care of brain health |
| 07/28/2004 | CN1159015C Use of silbene glycoside in treating dementia |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/28/2004 | CN1158996C Medicinal aerosol formulations |
| 07/27/2004 | US6768011 Antidepressants; reacting 3-(4-fluoro-), 6-cyanoisobenzofuranwith alkylation agent |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767907 For therapy of psychic and neurologic disorders |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2219911C Combinations for the treatment of parkinsonism containing selective nmda antagonists |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |
| 07/24/2004 | WO2003059904A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 07/22/2004 | WO2004060882A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060880A1 Aminoalkyl thiazole derivatives as kcnq modulators |
| 07/22/2004 | WO2004060858A1 Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
| 07/22/2004 | WO2004060403A2 Aprotinin and anglos as carriers across the blood-brain barrier |
| 07/22/2004 | WO2004060400A1 Antipsychotic molecular-targeting epithelial growth factor receptor |
| 07/22/2004 | WO2004060381A1 Rabbit skin comprising biological active substance and its use |
| 07/22/2004 | WO2004060374A1 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 07/22/2004 | WO2004060361A2 Combination of reboxetine and a cyclooxygenase-2 inhibitor |
| 07/22/2004 | WO2004060266A2 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 07/22/2004 | WO2004060265A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004043456A8 Cholesterol absorption inhibitors for the treatment of demyelination |
| 07/22/2004 | WO2004041269A3 New use for pharmaceutical composition |
| 07/22/2004 | WO2004039313A3 Preventing desensitization of receptors |
| 07/22/2004 | WO2004035086A3 Method for treatment of demyelinating central nervous system disease using gm-csf |
| 07/22/2004 | WO2004033498A3 .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof |
| 07/22/2004 | WO2004029229A3 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 07/22/2004 | WO2004026331A8 Peptides inhibiting specific cleaving activities of presenilins |
| 07/22/2004 | WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 07/22/2004 | WO2003094965A3 Modulation of neural stem cells with s1p or lpa receptor agonists |
| 07/22/2004 | WO2003087086A3 Substituted indoles |
| 07/22/2004 | WO2003076426A3 Pyridinyloxy derivatives as 5-ht receptor ligands |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | WO2003028668A3 Gammaglobulin treatment of immune disorders |
| 07/22/2004 | WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040143020 Psychological and central nervous system disorders |
| 07/22/2004 | US20040143014 Therapeutic use of alpha-2-delta ligands |
| 07/22/2004 | US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 07/22/2004 | US20040142997 Alzheimer's disease |
| 07/22/2004 | US20040142988 Bladder diseases; bone diosrders; central nerevous system diosrders |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142972 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 07/22/2004 | US20040142970 Treatment of hyperkinetic movement disorder with donepezil |
| 07/22/2004 | US20040142967 Pain maintenance |
| 07/22/2004 | US20040142966 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/22/2004 | US20040142965 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/22/2004 | US20040142964 Novel compounds |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142959 Method of treatment |
| 07/22/2004 | US20040142958 Combination therapy for the treatment of pain |
| 07/22/2004 | US20040142955 Psychological disorders; anxiolytic agents; antidepressants; bipolar disorders; analgesics; asthma ; hypotensive agents; obesity; antiepileptic agents; eating disorders; antidiabetic agents; irritable bowel disorders; Alzheimer's disease; cognition |
| 07/22/2004 | US20040142951 3H-quinazolin-4-one derivatives as MAO-B inhibitors |
| 07/22/2004 | US20040142936 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 07/22/2004 | US20040142935 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor liqands and/or serotonergic ligands |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142933 treatment of schizophrenia and other central nervous system (CNS) disorders |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142926 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder |
| 07/22/2004 | US20040142925 Piperazine derivatives their preparation and uses in therapy |
| 07/22/2004 | US20040142923 inhibitors of urotensin II |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142911 acetone, a salicylate-based compound, an emollient and one or more terpenes and essential oils; treating pain associated with cancer |
| 07/22/2004 | US20040142882 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142872 Polyamine modified antibodies having specific binding affinity for A beta also have increased permeability at the blood-brain barrier and can be used for passive immunization and treatment of Altzheimer's disease |
| 07/22/2004 | US20040142860 Central nervous system-derived immune privilege factor and uses thereof |
| 07/22/2004 | US20040142854 internalization sequence covalently linked to the modulating agent, a liposome that encapsulates the modulating agent or an antibody or ligand that binds to a cell surface receptor; alopecia |
| 07/22/2004 | US20040142851 by inducing the apoptosis according to a inhibition mechanism of the enzyme activities of proteasome |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142349 kit for detecting a risk of cancer, coronary or cerebrovascular disease, hypertension, type 2 diabetes, dementia, joint arthrosis, cataract, or sensitivity to organophosphorus compounds |
| 07/22/2004 | US20040142047 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 07/22/2004 | US20040142033 releases the following quantities of oxcarbazepine:15 min: 55 to 85%30 min: 75 to 95%45 min: 85 to 100%60 min: 90 to 100%in vitro |
| 07/22/2004 | US20040141984 Amyloid beta 1-6 antigen arrays |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141947 Method for treatment of demyelinating central nervous system disease |